Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: A randomized controlled trial

Military Medicine

Volumn 177, Issue 3, 2012, Pages 345-351

  Safi, Najibullah ^a   Davis, Gary D ^b   Nadir, Mohammed ^a   Hamid, Hamida ^c   Robert, Leon L ^d   Case, Alan J ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATO Training Mission Afghanistan   (Afghanistan)

^c Research Department   (Afghanistan)

^d UNITED STATES MILITARY ACADEMY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INTRALESIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; TREATMENT OUTCOME; WAR;

ADOLESCENT; ADULT; AFGHAN CAMPAIGN 2001-; AGED; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRALESIONAL; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860710198     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-11-00161     Document Type: Article

References (18)

1. Desjeux P: The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001; 95: 239-43.
2. Herwaldt B: Leishmaniasis. Lancet 1999; 354: 1191-9.
3. Griffiths W: Old World cutaneous leishmaniasis. In: The Leishmaniasis in Biology and Medicine, Vol. 2. Clinical Aspects and Control, pp 617-36. Edited by Peters W, Killick-Kendrick R, New York, NY, Academic Press, 1987.
4. Kassi M, Kassi M, Afghan AK, Rehman R, Kasi PM: Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan. PLoS Negl Trop Dis 2008; 2(10): e259.
5. Desjeux P: Leishmaniasis: public health aspects and control. Clin Dermatol 1996; 14: 417-23.
6. World Health Organization: The World Health Report 2002. Reducing Risks, Promoting Healthy Life, pp 186-87, 192-93. Geneva, Switzerland, WHO, 2002.
7. Reithinger R, Coleman PG: Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. BMC Infect Dis 2007; 7: 3.
8. Ashford R, Kohestany KA, Karimzad MA: Cutaneous leishmania in Kabul: observations on a prolonged epidemic. Ann Trop Med Parasitol 1992; 86: 361-71.
9. Rowland M, Munir A, Durrani N, Noyes H, Reyburn H: An outbreak of cutaneous leishmaniasis in an Afghanistan refugee settlement in northwest Pakistan. Trans R Soc Trop Med Hyg. 1999; 93: 133-6.
10. Handmann E: Leishmania: current status of vaccine development. Clin Microbiol Rev 2001; 14: 229-43.
11. González U, Pinart M, Reveiz L, Alvar J: Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev 2008; (4): CD005067.
12. Frézard F, Demicheli C, Ribeiro RR: Pentavalent antimonials: new perspectives for old drugs. Molecules 2009; 14: 2317-36.
13. Croft SL, Yardley V: Chemotherapy of leishmaniasis. Curr Pharm Des 2002; 8: 273-301.
14. Bryceson A: A policy for leishmaniasis with respect to the prevention and control of drug resistance. Trop Med Int Health 2001; 6: 928-34.
15. Navin TR, Arana BA, Arana FE, et al: Placebo-controlled clinical trial of meglumine antimonite (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 1990; 42: 43-50.
16. Velasco-Castrejon, Walton BC, Rivas-Sanchez B, et al: Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am J Trop Med Hyg 1997; 57: 309-12.
17. Central Statistics Office of the Islamic Republic of Afghanistan: Comparison of thermotherapy by radiofrequency and intra-lesional or intramuscular administration of antimonials in the treatment of small lesions leishmaniasis [CD-ROM]. Kabul, Afghanistan, Afghanistan Statistical Yearbook. SY1382, 2003.
18. Reithinger R, Mohsen M, Wahid M, et al: Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 2005; 40: 1148-55.